A1 and A2 milk come from the same animal, look identical in the glass, and share virtually the same nutritional profile. The difference is a single amino acid swap in one of milk’s major proteins, beta-casein, which changes what happens when you digest it. That tiny structural change has launched a global niche-milk industry and a still-evolving scientific debate about whether the protein in conventional milk contributes to digestive discomfort in some people.
One Amino Acid, Two Proteins
Beta-casein is one of the most abundant proteins in cow’s milk, and it exists in several genetic variants. The two that matter commercially are called A1 and A2. They differ at just one spot along the protein chain: position 67. In the A2 variant, that position holds the amino acid proline. In the A1 variant, a mutation swapped proline for histidine.1PubMed Central. Milk proteins and human health: A1/A2 milk hypothesis Every cow carries two copies of the beta-casein gene, one from each parent, so a given animal can be A1A1, A1A2 (heterozygous), or A2A2. “A2 milk” on a label means the milk came exclusively from cows that tested A2A2, producing none of the A1 variant in their milk.
The A2 variant is actually the older, ancestral form of the protein. The A1 mutation arose thousands of years ago in European cattle herds and spread widely through breeds like Holstein-Friesian, which became the backbone of industrial dairy farming. Because most conventional milk is pooled from large herds containing a mix of A1A1, A1A2, and A2A2 cows, a typical carton of milk contains both protein types.
Why the Difference Matters During Digestion
The histidine at position 67 in A1 beta-casein makes the protein chain easier for digestive enzymes to clip at that exact spot. When enzymes break A1 beta-casein apart, they release a seven-amino-acid fragment called beta-casomorphin-7, or BCM-7. Lab digestion studies confirm that casein from conventional milk releases significantly more BCM-7 than casein from A2-only milk.2Journal of Functional Foods. A simple method to generate β-casomorphin-7 by in vitro digestion of casein from bovine milk Because proline sits at the same position in A2 beta-casein, the enzyme cut happens far less readily, and much less BCM-7 is produced.
BCM-7 is classified as an opioid peptide, meaning it can bind to the same type of receptor (the mu-opioid receptor) found throughout the gut, the immune system, and to some extent the nervous system.3PubMed Central. Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants-A Review Opioid receptors in the gut help regulate motility, which is one reason researchers have looked at BCM-7 as a possible contributor to digestive symptoms like bloating, irregular stool consistency, and slowed transit time. Whether the amount of BCM-7 that survives digestion and absorption in a living human is large enough to produce meaningful effects is the central question the science is still working through.
What Clinical Trials Actually Show
Several randomized crossover trials have compared gut symptoms in people drinking A1-containing milk versus A2-only milk, and the results lean in a consistent direction without being slam-dunk proof.
A widely cited Chinese trial involving people who self-reported milk intolerance found that drinking milk with both A1 and A2 beta-casein was associated with worse digestive symptoms, higher inflammation markers, slower gut transit, and even increased errors on a cognitive test, compared to drinking A2-only milk. Importantly, A2-only milk did not worsen symptoms compared to a dairy-free baseline, in either lactose-tolerant or lactose-intolerant participants.4PubMed Central. Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows’ milk A smaller Australian pilot study similarly found that A1 milk led to softer stools, a strong correlation between abdominal pain and stool consistency, and higher fecal calprotectin (a marker of gut inflammation) in susceptible individuals.5European Journal of Clinical Nutrition. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study
A Korean trial added some nuance. Participants drinking A2-only milk reported less abdominal pain, less fecal urgency, and less stomach rumbling than those on A1/A2 milk. But A2 milk actually increased bloating and loose stools on a different symptom scale. Fecal calprotectin, the inflammation marker, decreased more with A2 milk, especially in men.6PubMed Central. The Effect of A2 Milk on Gastrointestinal Symptoms in Comparison to A1/A2 Milk: A Single-center, Randomized, Double-blind, Cross-over Study Results like these are why the picture remains somewhat mixed: the direction of benefit generally favors A2, but individual symptom measures do not always agree.
A single-meal crossover study focused specifically on people with lactose maldigestion found that A2-only milk produced lower total symptom scores for abdominal pain and lower hydrogen production (a sign of undigested lactose reaching the colon) compared to conventional milk.7PubMed Central. Milk Containing A2 β-Casein ONLY, as a Single Meal, Causes Fewer Symptoms of Lactose Intolerance than Milk Containing A1 and A2 β-Caseins in Subjects with Lactose Maldigestion and Intolerance That finding is interesting because it suggests the A1/A2 difference might matter even for people whose primary problem is lactose, not protein. One hypothesis is that BCM-7 slows gut transit, which gives bacteria more time to ferment undigested lactose and amplify symptoms.
Where the Scientific Consensus Stands
Multiple systematic reviews, all following established quality checklists, have looked at the controlled human and animal evidence together. Their shared conclusion is that A2 milk does appear to offer gastrointestinal benefits compared to A1-containing milk, but that evidence for A1 beta-casein causing broader health harm (cardiovascular disease, type 1 diabetes, neurological conditions) is rated very low in certainty.8PubMed Central. A2 Milk and BCM-7 Peptide as Emerging Parameters of Milk Quality The gut-comfort findings are the most reproducible. The bigger disease claims, which fueled some of the early A2 milk marketing, are largely unsupported by human trial data.
It is worth noting that BCM-7 is not unique to A1 milk. Both A1 and A2 beta-casein can release BCM-7 under certain conditions, though A1 produces far more.9PubMed Central. BCM-7: Opioid-like Peptide with Potential Role in Disease Mechanisms BCM-7 also shows up during cheese ripening, which means fermented dairy products made with conventional milk contain some regardless of the beta-casein genotype.8PubMed Central. A2 Milk and BCM-7 Peptide as Emerging Parameters of Milk Quality One recent study measured BCM-7 levels in raw and processed milk and found they were low across the board, with no significant difference by genotype or processing method.10Europe PMC / International Journal of Molecular Sciences. β-Casein A1 and A2 Genetic Variants and β-Casomorphin-7 in Raw Milk and Processed Milk Products The implication is that BCM-7 formation may depend heavily on what happens inside your gut rather than on what is already in the carton.
A2 Milk and Lactose Intolerance Are Not the Same Thing
A common misconception is that A2 milk is “lactose-free.” It is not. A2 milk contains the same amount of lactose as conventional milk. If you are severely lactose intolerant because your body makes very little lactase enzyme, A2 milk will still give you trouble. A recent trial tested this directly by giving lactose-intolerant and lactose-tolerant participants both A2 milk (with lactose) and lactase-treated A2 milk (lactose removed). Lactose-intolerant participants still showed elevated breath hydrogen after drinking A2 milk with its lactose intact, confirming the lactose issue remains real.11PubMed Central. Lactase-Treated A2 Milk as a Feasible Conventional Milk Alternative: Results of a Randomized Controlled Crossover Trial to Assess Tolerance, Gastrointestinal Distress, and Preference for Milks Varying in Casein Types and Lactose Content
That said, the overlap between A1-sensitivity and lactose intolerance in real life is probably why some people feel better on A2 milk and assume it “fixed” their lactose problem. If your symptoms from conventional milk are partly driven by BCM-7 slowing your gut and amplifying lactose fermentation, switching to A2 might reduce the total symptom load even though the lactose itself has not changed. For people whose symptoms are entirely about lactose, however, A2 milk alone is not a substitute for lactose-free products.
Which Cow Breeds Produce A2 Milk
Not all dairy breeds carry the A1 mutation at the same rate. Breeds that originated outside Europe, or that were less intensively selected for industrial milk production, tend to carry much higher frequencies of the A2 allele. Gyr cattle (a zebu breed from South Asia) have the highest A2 allele frequency in studies, around 85%, and Jersey cattle follow at roughly 73%.12Frontiers in Veterinary Science. Differential A1/A2 β-casein (CSN2) gene-derived allelic and genotypic frequencies across Ecuadorian exotic dairy cattle breeds The A1A1 genotype was entirely absent in the Gyr cattle studied. Holstein-Friesians, the dominant dairy breed worldwide, have A2 allele frequencies in the range of 63 to 68%, meaning roughly a third or more of their beta-casein genes are A1.13PubMed Central. The variation in the beta-casein genotypes and its effect on milk yield and genomic values in Holstein-Friesian cows Brown Swiss and crossbred cattle sit in a similar range.
Goat, sheep, and human milk naturally contain predominantly A2-type beta-casein, which is one reason some researchers have speculated that the relative novelty of A1 in the human diet (appearing only with certain cattle breeds and only in the last few thousand years) might partly explain why some people react poorly to it.
What Happens When Dairy Farmers Select Hard for A2
The commercial demand for A2 milk has created breeding pressure to produce herds of exclusively A2A2 cows. In principle, this is straightforward: genotype every animal, breed only A2A2 bulls to A2A2 or A1A2 cows, and cull or redirect A1A1 animals over a few generations. In practice, aggressive selection for a single gene in a population that is already somewhat inbred (as modern Holsteins are) raises real concerns about genetic diversity.
An Australian study found that A2A2 Holstein cows were twice as likely to have long stretches of identical DNA around the beta-casein locus compared to A1A1 cows, a sign of increased inbreeding in that region of the genome. While A2A2 cows had a slight advantage in protein yield, they were on average inferior in fertility. The net effect on overall economic value was only a tiny edge for A2A2 animals, suggesting that strong selection for the A2 allele alone could harm long-term genetic progress across traits that matter for farm profitability.14Frontiers in Animal Science. Evaluating the potential impact of selection for the A2 milk allele on inbreeding and performance in Australian Holstein cattle A separate study of organic Holstein herds found no meaningful difference in milk production or fertility between genotypes, though survival during first lactation was slightly lower for cows carrying the A1 allele.15PubMed Central. Relationships of beta-casein genetics with production, fertility, and survival of purebred organic Holstein dairy cows
The takeaway for consumers is that A2 milk is not simply a matter of choosing the right breed and walking away. There are real genetic trade-offs that dairy producers navigate, and rapid conversion of herds to A2A2 could narrow the gene pool in ways that create problems down the line.
A2 Infant Formula
The infant nutrition space has picked up the A2 story quickly, partly because human breast milk naturally contains an A2-type beta-casein. Several manufacturers now offer infant formulas made from A2-only cow’s milk. Lab studies show that these formulas release significantly less BCM-7 during simulated digestion compared to conventional formulas. One study found that an A2-based formula released about a third to half the BCM-7 of three commercially available conventional formulas under the same conditions.16PubMed Central. Production of Cow’s Milk Free from Beta-Casein A1 and Its Application in the Manufacturing of Specialized Foods for Early Infant Nutrition
A randomized controlled trial comparing A1-protein-free formula to conventional formula in infants who also received breast milk found that babies on the A2 formula had less spitting up, less crying, and less fussiness after four weeks. Caregivers reported improved relief of gastrointestinal symptoms at a higher rate than caregivers using conventional formula. Growth was normal in both groups.17PubMed Central. Effect of Infant Formula Made With Milk Free of A1 ‐Type β‐Casein on Growth and Comfort: A Randomized Controlled Trial These results are encouraging, though still from a limited number of trials. No major pediatric authority has yet recommended A2 formula specifically over conventional formula as a blanket guideline.
How A2 Milk Is Verified
If you have ever wondered whether A2 milk on the shelf is genuinely free of A1 beta-casein, the answer comes down to two layers of testing. The first is genetic: cows are DNA-tested to confirm they carry two copies of the A2 allele. Only confirmed A2A2 animals contribute to the milk pool. The second layer is direct protein testing of the milk itself. Researchers have developed laboratory methods sensitive enough to detect as little as 5% contamination by A1 beta-casein in a milk sample, providing a tool for catching mix-ups in the supply chain.18Journal of Dairy Science. Determination of A1 and A2 β-casein in cow milk by high-performance liquid chromatography tandem mass spectrometry For consumers, this means the “A2” label on products from established brands is generally backed by both genetic and analytical verification, though independent auditing practices vary by market and regulatory framework.
Effects Beyond the Gut
Some researchers have looked at whether the A1/A2 difference matters for anything beyond digestion. An updated review noted that newer clinical studies found effects of the A1 variant on serum glutathione levels (an antioxidant marker), cognitive performance scores in children, and mood scores in women.19Europe PMC / International Journal of Molecular Sciences. Does a Little Difference Make a Big Difference? Bovine β-Casein A1 and A2 Variants and Human Health-An Update These findings come from a small number of studies and are far from settled science. The opioid-receptor pathway through which BCM-7 could theoretically affect brain function exists, but the question of whether enough BCM-7 crosses the gut barrier and then the blood-brain barrier to produce real cognitive or mood effects in healthy adults remains open. The gut-related evidence is where the science is most consistent; everything beyond it is still speculative and should be treated as such.
For most people, the practical decision is straightforward. If you drink milk comfortably, there is no strong reason to switch to A2. If you experience digestive symptoms from milk and lactose-free versions do not fully resolve them, A2 milk is a reasonable experiment. The worst-case outcome is that you spent a bit more on milk that tastes the same and did not help. The best case, supported by a growing but still modest body of trial evidence, is that removing A1 beta-casein from your diet reduces gut inflammation and eases symptoms that were never about lactose in the first place.